Edition:
India

Arbutus Settles Litigation Terminating Acuitas Rights To LNP Technology


Friday, 23 Feb 2018 

Feb 22 (Reuters) - Arbutus Biopharma Corp ::ARBUTUS SETTLES LITIGATION, TERMINATING ACUITAS’ RIGHTS TO LNP TECHNOLOGY.ARBUTUS BIOPHARMA CORP - ‍SETTLEMENT TERMINATES ACUITAS' RIGHT TO USE OR SUBLICENSE OUR LNP TECHNOLOGY GOING FORWARD​.ARBUTUS BIOPHARMA - ‍SETTLEMENT STIPULATES THAT 4 NON-EXCLUSIVE VIRAL VACCINE SUBLICENSES PREVIOUSLY GRANTED TO MODERNA ARE ONLY SUBLICENSES TO SURVIVE​.ARBUTUS BIOPHARMA - LITIGATION INITIATED BY ACUITAS THERAPEUTICS ON OCT. 25, 2016 IN SUPREME COURT OF BRITISH COLUMBIA HAS BEEN SETTLED BEFORE TRIAL​. 

Company Quote

2.0
 --
23 May 2019